Exparel vs Block for ACL Reconstruction
Launched by ROTHMAN INSTITUTE ORTHOPAEDICS · Aug 22, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Paticipants with ACL rupture amenable to reconstruction with BTB autograft identified in clinic by one of 4 different surgeons
- • Primary ACL Reconstruction with Autograft +/- Partial meniscectomy +/- Lateral extra-articular tenodesis
- • Age 18 and older
- • English speaking
- • Ability to complete surveys by phone or in person
- • Ability to provide informed consent
- Exclusion Criteria:
- • Revision cases
- • Multi-ligamentous knee injuries
- • Cartilage or meniscal procedures that prevent adherence to immediate weight bearing and range of motion rehab protocol
- • ACL reconstruction utilizing non-bone-patellar tendon-bone autografts
- • Allergies to study medications
- • Non-English speakers
- • Known alcohol or narcotic abuse history
- • Existing contract with a pain specialist due to underlying preoperative pain syndrome
- • Preoperative opioid use within the 3 months prior to surgery
About Rothman Institute Orthopaedics
Rothman Institute Orthopaedics is a leading healthcare organization specializing in orthopedic care and research. With a commitment to advancing the field of orthopedics, Rothman Institute conducts innovative clinical trials aimed at improving patient outcomes and enhancing treatment methodologies. Renowned for its team of highly skilled orthopedic surgeons and researchers, the institute integrates cutting-edge technology and evidence-based practices to deliver exceptional care. Through its rigorous research initiatives, Rothman Institute is dedicated to fostering advancements in orthopedic medicine and contributing to the overall improvement of musculoskeletal health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported